Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratracheal surfactant plus budesonide to prevent bronchopulmonary dysplasia
IRCT20211107052993N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of budesonide in bronchopulmonary dysplasia (BPD) and respiratory distress syndrome (RDS), sponsored by Iran University of Medical Sciences. Started Nov 2021; status: completed.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20211107052993N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211107052993N1.